Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

He currently serves as the director of Sarcoma Pathways and is a physician at Dana-Farber Cancer Institute, in Boston, Massachusetts, where is also an instructor in medicine and an affiliated faculty ...